On the stock market since 2013, it operates in the world of money and finance. Now — the numbers.
The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.
An average decline of 6% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. For now, time is on the company’s side.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
Sales run at $2.1M a year. A small number, but proof the product has real buyers.
It pays out $0.55 per share each year — regular cash for whoever holds the stock.
A loss of $1.3M against $2.1M in annual sales. And on top of that, sales fell from the year before.
On our five-subject report card, OCSI sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: OCSI is a high-risk stock — not yet profitable, and its future rides on its product catching on.